FDA Slaps Four Companies for Marketing Cannabidiol Products as Disease Treatments

November 6, 2017

The FDA warned four companies for illegally branding cannabidiol products as treatments for cancer and Alzheimer’s disease.

Cannabidiol (CBD), derived from the marijuana plant, is not approved for use in any drug products. It is marketed in various forms including capsules, syrups, lotions and oil drops.

The FDA issued warning letters for products that marketed CBD products with unsubstantiated claims that it could prevent or cure cancer, as well as inhibiting tumors or cancer cells. The companies also marketed some products as Alzheimer’s treatments.

The agency issued warning letters to Natural Alchemist, Stanley Brothers Social Enterprises, Greenroads Health and That’s Natural! Marketing and Consulting, listing more than two dozen products.

View today's stories